Публикация в PubMed

PubMed – это реферативная база данных журнальных статей, книг и документов, включающая в свою основную подгруппу MEDLINE. Данная электронная научная библиотека (PubMed) предоставляет широкий спектр книг и ресурсов по биомедицине, здравоохранению и естественным наукам.

Журнал выпускается Национальным центром биотехнологической информации (NCBI), входящим в состав Национальной медицинской библиотеки. PubMed, который доступен для поиска через веб-сайт NLM, также включает в себя доступ к дополнительным ссылкам на отдельные журналы по наукам о жизни, не входящие в MEDLINE, в том числе ссылки на другие ресурсы, такие как: полнотекстовая версия статьи на веб-сайтах рецензируемых изданий, базы данных молекулярной биологии NCBI и PubMed Central.

Методические рекомендации по оформлению статьи PubMed:

  1. Данные автора, например:

Thromb Haemost. 2020 Apr 21. doi: 10.1055/s-0040-1710019;

  • Название статьи, например:

Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.

  • Соавторы (при наличии), например:

Zhai Z#1,2,3, Li C#4, Chen Y#5, Gerotziafas G6, Zhang Z7, Wan J1,2,3, Liu P8, Elalamy I6,9, Wang C1,2,3,10

  • Данные об авторах, например:

Prevention Treatment of VTE Associated with COVID-19 Infection Consensus Statement Group, Pulmonary Embolism Pulmonary Vascular Diseases Group of the Chinese Thoracic Society, Pulmonary Embolism Pulmonary Vascular Disease Working Committee of Chinese Association of Chest Physicians, National Cooperation Group on Prevention Treatment of Pulmonary Embolism Pulmonary Vascular Disease, National Program Office for Prevention Treatment of Pulmonary Embolism Deep Vein Thrombosis, China Grade Center, Evidence-based Medicine Center of School of Basic Medical Sciences of Lanzhou University.

  • Информация о должности и месте работы авторов исследования, например:

1Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.

2Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.

3National Clinical Research Center for Respiratory Diseases, Beijing, China.

4Department of Pulmonary and Critical Care Medicine, Affiliated Hospital of Jianghan University, Wuhan, China.

5Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.

6Hematology and Thrombosis Center, Tenon University Hospital, INSERM UMRS 938, Sorbonne University, Paris, France.

7Department of Clinical Laboratory, Wuhan Asia Heart Hospital, Wuhan, China.

8Department of Cardiovascular Surgery, China-Japan Friendship Hospital, Beijing, China.

9Department of Obstetrics and Gynaecology, the First I.M. Sechenov Moscow State Medical University, Moscow, Russia.

10Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

#Contributed equally (т.е. пометка о том, что в исследование внесён равноценный вклад).

  • Аннотация, например:

Abstract

Coronavirus disease 2019 (COVID-19) has caused a global pandemic in just a few months, causing millions infected. Nearly 20% of COVID-19 patients present severe coagulation abnormalities, which may occur in almost all of the severe and critical ill COVID-19 cases. Concomitant venous thromboembolism (VTE), a potential cause of unexplained deaths, has been frequently reported in COVID-19 cases, but its management is still challenging due to the complexity between antithrombotic therapy and coagulation disorders. Based on frontline practical experience and comprehensive literature review, here a panel of experts and physicians from China and Europe developed an evidence and opinion-based consensus on the prophylaxis and management of VTE associated with COVID-19. This statement aims for clinicians treating COVID-19 and provides practical recommendations in detailed situations, for example, how to choose thromboprophylactic measures for patients with diverse severity of disease and bleeding risk, or which kind of anticoagulant should be prescribed. With limited experience on COVID19-associated VTE, this expert consensus statement should be helpful for clinicians worldwide with specific suggestions.

  • Данные об авторе, который ответственен за процесс публикации статьи, например:

Georg Thieme Verlag KG Stuttgart · New York.

PMID: 32316065 DOI: 10.1055/s-0040-1710019

  • Конфликт интересов, например:

None declared.

  • Грантовая поддержка, например:

Chinese Academy of Engineering emergency research and cultivation project for COVID-19/2020-KYGG-01-05/

National Key Research and Development Program of China/2016YFC0905600/

National Key Research and Development Program of China/2016YFC0901104/

CAMS Innovation Fund for Medical Sciences/2018-I2M-1-003/

National Natural Science Foundation of China/81570049/

National Natural Science Foundation of China/81970058/

  1. Дополнительные ресурсы LinkOut, например:

Full Text Sources

Georg Thieme Verlag Stuttgart, New York

  1. Основной текст статьи.
  2. Список использованной литературы.

[1] Пример оформления статьи взят с официального сайта PubMed (https://www-ncbi-nlm-nih-gov.ezproxy.u-pec.fr/pubmed/32316065/).